Braille Institute Library to Host Livestream Event with Pulitzer Prize Finalist Andrew Leland on January 16, 2025
Leland to discuss his best-selling book, “The Country of the Blind: A Memoir at the End of Sight” LOS ANGELES,...
Leland to discuss his best-selling book, “The Country of the Blind: A Memoir at the End of Sight” LOS ANGELES,...
Dravet syndrome is a genetic developmental and epileptic encephalopathy (DEE) often caused by a mutation in SCN1A This is the...
Hoesman, Access Living to Advance Inclusion for 'Nation's Largest Minority Group' CHICAGO, Dec. 17, 2024 /PRNewswire/ -- Scott Hoesman, CEO and...
Secondary analysis of a randomized, placebo-controlled study of 1,000+ participants indicated that FDA-authorized RelieVRx® yielded clinically meaningful pain intensity and pain...
Groundbreaking thinkALS™ Tool Empowers Providers to Identify and Refer Patients Quicker ARLINGTON, Va., Dec. 10, 2024 /PRNewswire/ -- It can take...
Collaboration Focuses on Streamlining VA Disability Claims, Expanding Veteran Support Services, and Enhancing Resources AUSTIN, Texas, Dec. 4, 2024 /PRNewswire/...
Redefining Advocacy for the Injured and The Unsettling Truth About SettlingTORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- In an effort...
Focused Ultrasound Therapy for tremors is now available for patients with Dr. Taghva in Orange County MISSION VIEJO, CAPELLEN /...
Nes-Ziona, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy...
The sNDA submission is based on positive results from Studies 501 and 502 demonstrating CAPLYTA’s robust antidepressant efficacy and favorable...
HO CHI MINH CITY, Vietnam, Nov. 29, 2024 /PRNewswire/ -- After several years of intensive investment in R&D, TMA Solutions launched...
Two top healthcare awards underline Brainomix's landmark achievements in 2024 and the validation of its software's impact on treatment ratesOXFORD,...
TORONTO, ON / ACCESSWIRE / November 27, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ")...
WOBURN, Mass., Nov. 26, 2024 /PRNewswire/ -- Report by Parlance: In October 2024, Hurricane Milton ravaged Florida's Gulf Coast, leaving...
MIAMI, FL, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
Contract Unlocks Significant Market Opportunities Across Federal Healthcare SystemsROSELAND, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:...
After a successful 6-week pilot program, Nabla's ambient AI assistant is rolling out to Catalight's clinical team of case managers,...
NEW YORK, Nov. 25, 2024 /PRNewswire/ -- The global benefits administration service market size is estimated to grow by USD 144.7...
Presentations include first reporting of data for the RESET™ Clinical Trial evaluating SPRINT PNS versus Standard Interventional Management for low...
World Class Health's pioneering benefit has achieved a stellar 1.6% readmission rate and delivered a 90+ NPS from nearly 4,000...